<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03118791</url>
  </required_header>
  <id_info>
    <org_study_id>ACND</org_study_id>
    <nct_id>NCT03118791</nct_id>
  </id_info>
  <brief_title>Dose-Dependent Effects of Anthocyanins on Endothelial Function in Healthy Men</brief_title>
  <official_title>Investigation on Acute Dose-Dependent Effects of Anthocyanins on Endothelial Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anthocyanins are a subclass of (poly)phenols very abundant in berries and red grapes.
      Increasing evidence from human epidemiological and dietary intervention studies suggests that
      anthocyanins may have cardiovascular health benefits. The present study aimes to investigate
      whether pure anthocyanin consumption improves endothelial function in healthy individuals and
      if these effects are dose-dependent.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anthocyanins are a subclass of (poly)phenols very abundant in berries and red grapes.
      Increasing evidence from human epidemiological and dietary intervention studies suggests that
      anthocyanins may have cardiovascular health benefits. A double blind randomized controlled
      crossover, dose-response study will be conducted in 10 young healthy men. On 6 different
      days, subjects will consume capsules containing 0, 80, 160, 240, 320 and 480 mg of purified
      anthocyanins with a one-week wash-out period. Flow-mediated dilation (FMD) and blood pressure
      will be measured at baseline and at 2 and 6 h after consumption. Blood samples will also be
      taken and quantification of plasma anthocyanin metabolites using UPLC-Q-TOF-MS will be
      performed. The aim is to investigate whether purified anthocyanins are able to increase FMD
      at 2h and 6h post consumption and whether these effects correlate with anthocyanin- derived
      phenolic acids quantified in the plasma.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 7, 2017</start_date>
  <completion_date type="Actual">October 31, 2017</completion_date>
  <primary_completion_date type="Actual">August 8, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Double blind randomized controlled crossover</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>Changes from baseline to 2 hours postconsumption</time_frame>
    <description>Flow-mediated dilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>0 and 2 hours postconsumption</time_frame>
    <description>Automatic measurements</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Other Pre-specified Outcome Measures</measure>
    <time_frame>0 and 2 hours postconsumption</time_frame>
    <description>Plasma (poly)phenol metabolites measured by ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-Q-TOF MS)</description>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy Men</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Capsules containing maltodextrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>80 mg ACN</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Capsules containing 80 mg anthocyanins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>160 mg ACN</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Capsules containing 160 mg anthocyanins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>240 mg ACN</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Capsules containing 240 mg anthocyanins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>320 mg ACN</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Capsules containing 320 mg anthocyanins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>480 mg ACN</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Capsules containing 480 mg anthocyanins</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>anthocyanins</intervention_name>
    <description>Acute intake of capsules</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>80 mg ACN</arm_group_label>
    <arm_group_label>160 mg ACN</arm_group_label>
    <arm_group_label>240 mg ACN</arm_group_label>
    <arm_group_label>320 mg ACN</arm_group_label>
    <arm_group_label>480 mg ACN</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men aged 18-45 years old

          -  Subjects are willing to maintain their normal eating/drinking habits and exercise
             habits to avoid changes in body weight over the duration of the study - subjects are
             able to understand the nature of the study

          -  able to give signed written informed consent

          -  signed written infomred consent form

          -  healthy male subjects (no clinical signs or symptoms of CVD.

        Exclusion Criteria:

          -  cardiovascular disease, acute inflammation, cardiac arrhythmia, renal failure, heart
             failure (NYHA II-IV), diabetes mellitus, C-reactive protein &gt; 0.5 mg/dL, malignant
             disease, hypotension (≤100 / 60 mm Hg)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine, University Hospital Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2017</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

